The new product launches are in a range of therapeutic areas, including diabetes, cardiovascular, gastroenterology, and orthopaedics
pharmaceutical manufacturers in uae
India’s Himalaya Wellness to open $54.4mn herbal pharmaceutical factory in Dubai
The Dubai plant will have an annual production capacity of 3 billion tablets, 15 million syrup bottles, and three million units of ointment, with plans to serve global volumes until 2030
Abu Dhabi-based Ethmar International Holding acquires stake in Al Ain Pharmacy
It is the first investment by Health Plus Holding, a subsidiary of Ethmar International Holding, which will focus on healthcare sector
Mubadala and Resilience to build biopharma manufacturing facility in Abu Dhabi
A first-of-its-kind facility in the region to manufacture life-saving drugs; Mubadala has invested in several equity rounds of Resilience
Abu Dhabi’s ADQ acquires Turkish pharma producer to boost UAE’s ability to manufacture health products
Turkey’s BMG, which specialises in freeze drying, is a production service provider for sterile injectable products, including vials and pre-filled syringes used for vaccines
Gabri Labs and Dubai Science Park ink agreement to construct AED18m medical devices facility in Dubai
UAE’s pharmaceutical industry is set to reach AED5.6bn by 2025 as initiatives such as Operation300bn attract firms to the country
Dubai Chamber of Commerce forms UAE Pharma Business Group to support local medicine manufacturers
The group’s 50 member companies will support the UAE’s ambitions to become a leading hub for the pharmaceutical, nutraceutical, and the medical device manufacturing industry
UAE’s Julphar sees near doubling of Q3 pharma sales to $100m
Chairman of Ras Al Khaimah-based company hails ‘positive trajectory’ after returning to profitability in 2021
Operation 300bn will take local pharma innovation global
Alongside artificial intelligence, space technologies, and energy, pharmaceuticals have been earmarked as having a vital future in the UAE’s industrial sector
Video: UAE to produce millions of Covid-19 shot doses after China partnership
The joint venture between Sinopharm CNBG and Abu Dhabi-based G42 is further proof of the UAE’s diversification strategy.
Abu Dhabi looks to become pharma hub after Sinopharm Covid-19 shot deal
UAE capital looks to distribute billions of vaccine doses
Covid-19 vaccine deal shows there’s more to UAE than oil, tourism, economist says
Partnership between Sinopharm CNBG and G42 will increase awareness of the country as a destination for FDI across a broader range of sectors
Sinopharm Covid-19 shot dubbed Hayat Vax for local rollout after UAE-China deal
Newly-created joint venture between Sinopharm CNBG and Abu Dhabi-based G42 aims to produce up to 200m doses of the coronavirus vaccine annually at a new plant that will become operational this year
UAE pharma giant posts $26m loss as Saudi ban weighs
CEO of Gulf Pharmaceutical Industries reports ‘disappointing’ second quarter net loss, remains cautious in outlook
UAE orders withdrawal of Julphar mouthwash over ‘impurities’
Ministry of Health and Prevention says product testing confirmed that it contained impurities that are both harmful and contaminated with bacteria
Julphar inks Dutch deal to bring new medicine to the UAE
UAE-based pharma firm signs agreement to offer new drugs for treatment of high cholesterol
UAE pharma giant signs deal to enter cancer drugs market
Julphar announces its entry into the oncology market through a licence and supply agreement with Russia’s BIOCAD